Potential limitations of electronic database studies of prescription non-aspirin non-steroidal anti-inflammatory drugs (NANSAIDs) and risk of myocardial infarction (MI)
- 15 June 2005
- journal article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 14 (8) , 513-522
- https://doi.org/10.1002/pds.1129
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Risk of cardiovascular events and rofecoxib: cumulative meta-analysisThe Lancet, 2004
- Nonsteroidal Antiinflammatory Drugs and the Risk of Myocardial Infarction in the General PopulationCirculation, 2004
- The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirinJournal of the American College of Cardiology, 2004
- Agreement between GPRD smoking data: a survey of general practitioners and a population‐based surveyPharmacoepidemiology and Drug Safety, 2003
- Enhancement of medication recall using medication pictures and lists in telephone interviewsPharmacoepidemiology and Drug Safety, 2003
- Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarctionPublished by Wiley ,2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1999
- Effects of Nonsteroidal Antiinflammatory Drugs on Platelet Function and Systemic HemostasisThe Journal of Clinical Pharmacology, 1995
- Evaluation of flurbiprofen for prevention of reinfarction and reocclusion after successful thrombolysis or angioplasty in acute myocardial infarctionEuropean Heart Journal, 1993